Serum luteinizing and follicle stimulating hormone levels during sequential and nonsequential contraceptive treatment of eugonadal women.
D000328:Adult; D002715:Chlormadinone Acetate / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000494:pharmacology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood* / Q000378:metabolism; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007986:Luteinizing Hormone / Q000097:blood* / Q000378:metabolism; D008598:Menstruation; D008656:Mestranol / Q000494:pharmacology*; D009641:Norethynodrel / Q000494:pharmacology*; D010060:Ovulation; D011863:Radioimmunoassay; D013268:Stimulation, Chemical
D003276:Contraceptives, Oral; D002715:Chlormadinone Acetate; D009641:Norethynodrel; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008656:Mestranol